E
Anika Therapeutics, Inc. ANIK
$21.99 -$0.75-3.30%
Recommendation
Sell
Prev Close
$22.74
Volume
28,303
Avg Vol (90D)
182,554
Market Cap
$332.93M
Dividend & Yield
--
52-Week Range
$16.54 - $32.33
P/E (TTM)
--
EPS (TTM)
-$1.69
My Lists My Alerts
Report
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Anika Therapeutics management to meet with Barrington
11/30/2023 - The Fly
Anika Therapeutics (ANIK, $22.08) price may drop as it broke higher Bollinger Band on Nov 28, 2023
11/29/2023 - Tickeron - Technical Analysis
Anika Announces First Surgeries Performed using the Integrity Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
11/28/2023 - Globe Newswire
Anika Therapeutics (ANIK, $21.22) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 24, 2023
11/25/2023 - Tickeron - Stocks
Anika Therapeutics (ANIK, $21.22) Stochastic Oscillator left the overbought zone on November 24, 2023
11/25/2023 - Tickeron - Stocks
Anika Therapeutics (ANIK, $20.58) Moving Average Convergence Divergence (MACD) Histogram turned negative on November 22, 2023
11/23/2023 - Tickeron - Technical Analysis
Anika Therapeutics, Inc. (NASDAQ:ANIK) Short Interest Update
11/17/2023 - Ticker Report
Anika to Participate in Upcoming Investor Conferences
11/7/2023 - Globe Newswire
Allspring Global Investments Holdings LLC Increases Position in Anika Therapeutics, Inc. (NASDAQ:ANIK)
11/7/2023 - Zolmax
Strong week for Anika Therapeutics (NASDAQ:ANIK) shareholders doesn't alleviate pain of five-year loss
11/6/2023 - Simply Wall St
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2023 Earnings Call Transcript
11/5/2023 - Insider Monkey
Anika Therapeutics (NASDAQ:ANIK) Given New $28.00 Price Target at Barrington Research
11/4/2023 - Ticker Report
Anika Therapeutics (ANIK, $21.12) price may drop as it broke higher Bollinger Band on Nov 03, 2023
11/4/2023 - Tickeron - Stocks
Anika Therapeutics, Inc. (ANIK) Q3 2023 Earnings Call Transcript
11/3/2023 - SeekingAlpha
Anika Therapeutics Receives Buy Rating Based on Strong Q3 Performance and Positive 2023 Outlook
11/3/2023 - TipRanks Financial Blog
Anika Therapeutics price target raised to $28 from $24 at Barrington
11/3/2023 - The Fly
Anika Therapeutics, Inc. 2023 Q3 - Results - Earnings Call Presentation
11/3/2023 - SeekingAlpha
Anika Therapeutics Inc (ANIK) Reports 3% Revenue Growth in Q3 2023, Raises Full-Year Guidance
11/2/2023 - GuruFocus
Anika Therapeutics reports Q3 EPS 0c, consensus (37c)
11/2/2023 - The Fly
Anika Therapeutics Non-GAAP EPS of $0.00 beats by $0.35, revenue of $41.5M beats by $3.23M
11/2/2023 - Seeking Alpha - Healthcare
Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business
11/2/2023 - Globe Newswire
Anika Therapeutics Q3 2023 Earnings Preview
11/1/2023 - Seeking Alpha - Healthcare
Anika Therapeutics (ANIK, $19.5) Moving Average Convergence Divergence (MACD) Histogram turned positive on October 31, 2023
11/1/2023 - Tickeron - Stocks
Critical Analysis: Anika Therapeutics (NASDAQ:ANIK) versus UFP Technologies (NASDAQ:UFPT)
10/28/2023 - Zolmax
Anika Therapeutics (ANIK, $18.85) Moving Average Convergence Divergence (MACD) Histogram turned negative on October 24, 2023
10/25/2023 - Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
$163.31M
EBITDA (TTM)
-$21.52M
EBIT (TTM)
-$35.83M
Net Income (TTM)
-$24.58M
Balance Sheet
Total Assets (Q)
$328.16M
Total Debt (Q)
$29.31M
Total Liabilities (Q)
$57.67M
Book Value Per Share (Q)
$18.48
Cash Flow
Cash from Operations (TTM)
-$4.95M
Cash from Investing (TTM)
-$6.12M
Cash from Financing (TTM)
-$6.00M
Net Change in Cash (TTM)
-$17.13M
Filings
Filing Date
Friday, November 3, 2023
Period Date
Saturday, September 30, 2023
Next Filing
Week of Mar 11 and 15 (est)
Price History
Loading...
Beta
0.67
7-Day Total Return
3.13%
30-Day Total Return
16.98%
60-Day Total Return
29.33%
90-Day Total Return
-5.49%
Year to Date Total Return
-25.20%
1-Year Total Return
-28.46%
2-Year Total Return
-43.82%
3-Year Total Return
-40.79%
5-Year Total Return
-31.39%
52-week Low
Sep 08, 2023 - $16.54
52-week High
Feb 21, 2023 - $32.33
Valuation
Market Cap
$332.93M - Small Cap
Enterprise Value
$291.59M
Price/Sales (TTM)
2.04
Price/Book (Q)
1.23
Dividends and Shares
Shares Outstanding
14.64M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.anikatherapeutics.com
Phone Number
781 457 9000
Address
32 Wiggins Avenue
Bedford, MA 01730
Country
United States
Year Founded
1983
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative... more
NASDAQ 12/06/2023 3:35PM Eastern Quotes delayed
Weiss Ratings